World Lymphoma Day 2020: Co-talk lymphoma management, to help patients towards cure.

On September 15, 2020, on the occasion of World Lymphoma Day, the Health Care Channel of the National Health Commission, the Rehabilitation Society of the Chinese Anti-Cancer Association, the Beijing Love Spectrum Cancer Patient Care Foundation, Lymphoma House and Roche Pharmaceuticals China jointly sponsored the Health China Action - Cancer Prevention and Control Special Action Theme Campaign and the "Born of beauty" World Lymphoma Day public education event was successfully held in Beijing.
This event brings together government representatives, authoritative experts, patient groups and caring people from all walks of life to pay tribute to the rapid development of China's lymphoma diagnosis and treatment cause with the three chapters of "Following the Road, Seeing the Present Dynasty and Showing the Future", focusing on the unfinished needs of lymphoma patients today, looking forward to a better future for the benefit of patients throughout the management, with the aim of raising public awareness of lymphoma diseases, promoting the community's care for lymphoma patients, strengthening patients' confidence in cure and helping to "health China 2030".
Photo Guests (left to right): Qian Qi, General Manager of Roche Pharmaceuticals China Oncology Division I, Ma Jun, Director of Harbin Institute of Hematology Oncology, Director of Pathology Department of Peking University Medical Department and Third Hospital of Peking University, Dr. Gao Zifen, Chairman of the Rehabilitation Committee of the Chinese Anti-Cancer Association, Shi Anli, Director of the Planning Development and Information Technology Department of the National Health And Health Commission, Director of the National Health And Wellness Commission, Zhu Jun, Director of Lymphoma Department, Peking University Cancer Hospital, Hong Fei, Founder of Lymphoma House, and Long Weili, Vice President of Chinese Enterprise Affairs and Communication Department of Roche Pharmaceuticals, paid tribute to the development of lymphoma prevention and treatment with Chinese characteristics, focusing on the special "Shape of Time" link of the event, and the guests were in love with the , will be a piece of old things behind the wind and rain, do not forget the first heart of the story, for the audience sketched out the cause of China's lymphoma prevention and treatment "steps, to thousands of miles" of the journey of seeking, showing ordinary and brilliant love, The truth touched everyone in the audience.
As the initiator of World Lymphoma Day, Professor Ma Jun, Director of Harbin Institute of Hematological Oncology, brought to you the old photos of 20 years of participating in various academic exchanges of lymphoma: "These photos are the testimony of me following the older generation of experts and scholars, representing China in the field of lymphoma international exchanges, it can be said that it carries the dream of China's lymphoma diagnosis and treatment 'walking' to the world stage."
20 years of wind and waves, more and more Chinese scholars for the vast number of urgently needed lymphoma patients to light the way forward.
" this activity to record the patient's voice with real images, focusing on the current lymphoma diagnosis and treatment process of the unfinished needs, causing patients to share.
" Three years ago, together with Roche, we officially launched the 'Born of Beauty' tour, hoping to use the annual 'World Lymphoma Day', with humane care to empower disease education, continue to voice for lymphoma patients, to help them firmly fight the disease confidence, enjoy a free and happy life.
" Professor Shi Anli, Chairman of the Rehabilitation Association of the Chinese Anti-Cancer Association, said, "This year, in order to further respond to the call of the National Health And Wellness Commission to promote cancer prevention and treatment work, 'born of beauty' relies on the Health China Action - cancer prevention and control special action theme publicity activities are fully carried out, through the assembly of government, experts, patients and other forces, from the needs of patients, accurate 'pulse', to help patients regain their vitality and rejuvenate their lives."
" co-talk lymphoma diagnosis and treatment of the whole management, to help patients towards cure lymphoma is a common malignant tumor originating from the lymphatic hematosis system, but also in recent years, one of the higher incidence of tumors.
data show that there are about 100,000 new lymphoma patients in China every year, and the incidence of the population is young trend, the prevention and treatment situation is serious.
", the overall five-year survival rate of patients with lymphoma in China is about 38%.
lymphoma patients in the United States had a five-year survival rate of 67%.
this gap are due to complex lymphatic division, high misdiagnosis, and a lack of standardized treatment for patients through full management.
," said Professor Tso Zifen, Director of Pathology at Peking University's Department of Medicine and Director of Pathology at Peking University's Third Hospital.
2019 White Paper on survival for patients with lymphoma showed that 43% of Patients with Lymphoma in China had experienced misdiagnosis; Hong Fei, founder of
Lymphoma Home, said: "Many patients who could have been cured have a poor prognosis due to missed opportunities for treatment, which places a heavy burden on individuals, families and society.
" to strengthen the standardized diagnosis and treatment of patients with lymphoma and full management, is the key to improve the effectiveness of treatment.
" clinicians should change from focusing on 'disease' to caring for 'patients', individualized and accurate treatment of patients, and truly from diagnosis, treatment, rehabilitation, to achieve the patient's entire life cycle of attention, maximize the quality of life and cure rate of patients, reduce the impact of treatment on the quality of life, and ultimately help patients achieve long-term benefits.
," said Professor Zhu Jun, director of the lymphoma department at Peking University Cancer Hospital.
to start the whole management innovation model, build "Healthy China 2030" 2020 is the national "13th Five-Year Plan" health China planning official year, but also "Healthy China 2030" action of the beginning of the new decade.
Recent years, the overall morbidity and mortality rate of cancer in China has been increasing year by year, and cancer has become a major public health problem threatening the health of our residents," said Mao Qun'an, Director of the Planning Development and Information Technology Department of the National Health and Health Commission.
This, the Party and the State attach great importance to this, in the Health China Action (2019-2030) clearly put forward cancer prevention and treatment as one of the major actions to promote cancer prevention, early screening and early diagnosis and treatment, standardized treatment, and ultimately achieve the 'by 2030, the overall cancer five-year survival rate increased by 15%' strategic goal.
" at the event site, representatives of all parties also jointly launched the "China lymphoma sub-specialty capacity-building project", aimed at playing the pioneering role of "model samples", for the future management innovation model throughout the country to take root, continue to expand, lay a solid foundation.
At the same time, in order to make the concept of full management more deeply rooted in the hearts of the people, "lymphoma management care white paper" will be released in the near future, covering lymphoma patients diagnosis and treatment, nursing, psychology and other aspects, to provide practical help to patients.
Hong, president of Roche Pharmaceuticals China, said: "Roche's three consecutive years of support for the 'Born for America' campaign is a practical implementation of the 'First Patient Needs' commitment.
as a leader in anti-blood tumors, Roche has long been committed to accelerating the introduction of innovative drugs to China to provide Chinese patients with richer and better anti-tumor solutions to meet the needs of individualized treatments.
, we will, as always, work closely with all sectors of society to continuously carry out disease education, and jointly build a full management system for patients with lymphoma to enhance their access to medical care.
believe that with the steady progress of the 'Healthy China Initiative' and the in-depth development of special actions for cancer prevention and treatment, the level of diagnosis and treatment of lymphoma in China will usher in more exciting development, and more lymphoma patients will embrace beautiful life because of our efforts.
"